J
Jutta Bergler-Klein
Researcher at Medical University of Vienna
Publications - 119
Citations - 5696
Jutta Bergler-Klein is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Ejection fraction & Heart failure. The author has an hindex of 32, co-authored 105 publications receiving 4198 citations. Previous affiliations of Jutta Bergler-Klein include University of Vienna.
Papers
More filters
Journal ArticleDOI
Natural History of Very Severe Aortic Stenosis
Raphael Rosenhek,Robert Zilberszac,Michael Schemper,Martin Czerny,Gerald Mundigler,Senta Graf,Jutta Bergler-Klein,Michael Grimm,Harald Gabriel,Gerald Maurer +9 more
TL;DR: Despite being asymptomatic, patients with very severe aortic stenosis have a poor prognosis with a high event rate and a risk of rapid functional deterioration and early elective valve replacement surgery should be considered in these patients.
Journal ArticleDOI
Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis
Jutta Bergler-Klein,Ursula Klaar,Maria Heger,Raphael Rosenhek,Gerald Mundigler,Harald Gabriel,Thomas Binder,Richard Pacher,Gerald Maurer,Helmut Baumgartner +9 more
TL;DR: In severe AS, natriuretic peptides provide important prognostic information beyond clinical and echocardiographic evaluation and neurohormones may gain particular importance for timing of surgery in asymptomatic severe AS.
Journal ArticleDOI
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Alexander R. Lyon,Teresa López-Fernández,Liam Couch,Riccardo Asteggiano,Marianne C Aznar,Jutta Bergler-Klein,Giuseppe Boriani,Daniela Cardinale,Raul Cordoba,Bernard Cosyns,D Cutter,Evandro de Azambuja,W. De Boer,Susan Dent,Dimitrios Farmakis,Sofie Gevaert,D. Gorog,A. Herrmann,Daniel J. Lenihan,Javid Moslehi,Brenda Moura,Sonja S Salinger,R. Stephens,Thomas M. Suter,Sebastian Szmit,Juan Tamargo,Paaladinesh Thavendiranathan,Carlo G. Tocchetti,P. Van Der Meer,Helena J H van der Pal +29 more
Journal ArticleDOI
Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction.
Marie-Annick Clavel,John G. Webb,J. Rodés-Cabau,Jean-Bernard Masson,Eric Dumont,R. De Larochellière,Daniel Doyle,Sébastien Bergeron,Helmut Baumgartner,Ian G. Burwash,Jean G. Dumesnil,Gerald Mundigler,Robert Moss,Aleksander Kempny,Rodrigo Bagur,Jutta Bergler-Klein,Ronen Gurvitch,Patrick Mathieu,P. Pibarot +18 more
TL;DR: In patients with severe aortic stenosis and depressed LV systolic function, TAVI is associated with better LVEF recovery compared with SAVR.
Journal ArticleDOI
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society
Alexander R. Lyon,Susan Dent,Susannah Stanway,Helena M. Earl,Christine Brezden-Masley,Alain Cohen-Solal,Carlo G. Tocchetti,Javid Moslehi,John D. Groarke,Jutta Bergler-Klein,Vincent Khoo,Vincent Khoo,Li Ling Tan,Markus S. Anker,Stephan von Haehling,Christoph Maack,Radek Pudil,Ana Barac,Paaladinesh Thavendiranathan,Bonnie Ky,Tomas G. Neilan,Y N Belenkov,Stuart D. Rosen,Zaza Iakobishvili,Aaron L. Sverdlov,Ludhmila Abrahão Hajjar,Ariane Vieira Scarlatelli Macedo,Charlotte Manisty,Fortunato Ciardiello,Dimitrios Farmakis,Dimitrios Farmakis,Rudolf A. de Boer,Hadi Skouri,Thomas M. Suter,Daniela Cardinale,Ronald M. Witteles,Michael G. Fradley,Joerg Herrmann,Robert F. Cornell,Ashutosh Wechelaker,Michael J. Mauro,Dragana Milojkovic,Hugues de Lavallade,Frank Ruschitzka,Andrew J.S. Coats,Petar M. Seferovic,Ovidiu Chioncel,Thomas Thum,Johann Bauersachs,M. Sol Andres,David Wright,Teresa López-Fernández,Chris Plummer,Daniel J. Lenihan +53 more
TL;DR: In this paper, the authors presented a risk stratification proformas for oncology patients prior to receiving cancer therapies known to cause heart failure or other serious cardiovascular toxicities, with the aim of improving personalised approaches to minimise the risk of cardiovascular toxicity from cancer therapies.